Stock comparison

AMGNvsVRTX

Amgen IncvsVertex Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

AMGN

Amgen Inc

$348.62

+6.70%

Biotechnology$188.8BNASDAQ

VRTX

Vertex Pharmaceuticals Inc

$435.1

-4.37%

Biotechnology$119.2BNASDAQ

60-day price, rebased to 100

AMGN +1.97% · VRTX -7.41%

Round-by-round

AMGN 3·VRTX 2· 1tie

Tie

Valuation upside

-41.60% vs -43.10% to DCF fair value

EdgeVRTX

Balance-sheet strength

Altman Z 1.78 vs 12.39

EdgeAMGN

Fundamental quality

Piotroski 8.00 vs 6.00 (of 9)

EdgeVRTX

Growth + margins

Rule-of-40 32.00 vs 35.50

EdgeAMGN

60-day momentum

+1.97% vs -7.41% price return

EdgeAMGN

Market-cap liquidity

$188.8B vs $119.2B

Verdict

Across6categories,AMGNtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onAMGNorVRTX

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.